1518 GMT - The health system in the U.K. needs to develop a more attractive investment environment, AstraZeneca's chief executive officer Pascal Soriot says in a media call. High taxes and access issues have created problems for the entire industry, he says. The British pharma giant last week withdrew plans to invest in a vaccine plant in Liverpool after what it called a cut in government support. Shares are up 5.8% at 117.70 pounds. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
February 06, 2025 10:18 ET (15:18 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。